KARD — Kardigan, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2123613 ·
Last close
$22.58
Market Cap
—
52W High
$24.86
52W Low
$16.25
ADV30
1,617,220
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -58,710,000 | -56,071,000 | 348,190,000 | 81,548,000 | 648,816,000 |
| Mar 2025 | 0 | — | -26,078,000 | -18,019,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-78,170,000
Investing CF
$14,509,000
Financing CF
$110,323,000
CapEx
$-3,175,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.43
As of
2026-06-17
Balance + Analyst (yfinance extras)
Retained Earnings
$-337,160,000
Inventory
—
Receivables
—
ST Investments
$205,560,000
EBIT TTM
$-84,788,000
Pretax Income TTM
$-78,257,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -201,836,000 | -191,941,000 | 390,942,000 | 641,277,000 | — | -151,056,000 |
| Dec 2024 | 0 | -96,656,000 | -88,658,000 | 63,526,000 | 146,720,000 | — | -18,825,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.01T | $1127.69 | — |
| JNJ | JOHNSON & JOHNSON | $589.48B | $244.88 | — |
| ABBV | AbbVie Inc. | $429.58B | $243.14 | — |
| MRK | Merck & Co., Inc. | $309.84B | $125.45 | — |
| NVS | NOVARTIS AG | $295.98B | $155.12 | — |
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-06-24 16:18:45 | 2026-06-22 | Arch Venture Partners Xiii, LLC | Dir, 10% | P - Purchase | 16 | 1250000 | 20000000 |
| 2026-06-24 21:26:05 | 2026-06-22 | Hrtg Gpe, LLC | 10% | P - Purchase | 16 | 3125000 | 50000000 |
| 2026-06-24 16:20:56 | 2026-06-22 | Berns Paul L | Dir, 10% | P - Purchase | 16 | 1250000 | 20000000 |